Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation

NCT00143117 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
460
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer